GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Organics Ltd (NSE:MEDIORG) » Definitions » Common Stock

Medicamen Organics (NSE:MEDIORG) Common Stock : ₹86.0 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medicamen Organics Common Stock?

Medicamen Organics's quarterly common stock increased from Mar. 2023 (₹60.0 Mil) to Sep. 2023 (₹80.0 Mil) and increased from Sep. 2023 (₹80.0 Mil) to Mar. 2024 (₹86.0 Mil).

Medicamen Organics's annual common stock stayed the same from Mar. 2022 (₹60.0 Mil) to Mar. 2023 (₹60.0 Mil) but then increased from Mar. 2023 (₹60.0 Mil) to Mar. 2024 (₹86.0 Mil).


Medicamen Organics Common Stock Historical Data

The historical data trend for Medicamen Organics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Organics Common Stock Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Common Stock
60.00 60.00 60.00 86.00

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24
Common Stock 60.00 60.00 60.00 80.00 86.00

Medicamen Organics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Medicamen Organics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd is engaged in developing, manufacturing, and distribution of broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government and private institutions as contract manufacturer/third party manufacturer. The company markets its product to private pharma companies in domestic as well as international markets through third-party distributors or on a loan license basis.

Medicamen Organics Headlines

No Headlines